Zimmer Biomet Holdings, Inc.

NYSE:ZBH

108.18 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 7,394.26,939.96,827.37,024.57,982.27,932.97,824.17,683.95,997.84,673.34,623.44,471.74,451.84,220.24,095.44,121.13,897.53,495.43,286.12,980.91,9011,372.41,178.61,040.6939861
Cost of Revenue 2,731.22,019.51,960.42,128.32,252.62,271.92,132.92,374.91,856.61,249.81,286.11,125.21,1221,012.4990.8997.3875.9780.1739.4779.9516.2344.8325.9290.9269265
Gross Profit 4,6634,920.44,866.94,896.25,729.65,6615,691.25,3094,141.23,423.53,337.33,346.53,329.83,207.83,104.63,123.83,021.62,715.32,546.72,2011,384.81,027.6852.7749.7670596
Gross Profit Ratio 0.6310.7090.7130.6970.7180.7140.7270.6910.690.7330.7220.7480.7480.760.7580.7580.7750.7770.7750.7380.7280.7490.7230.720.7140.692
Reseach & Development Expenses 458.7406435.8372449.3391.7367.4365.6268.8188.3204.2225.6238.6220205.4194209.6188.3175.5166.7105.880.771.6524536
General & Administrative Expenses 0003,177.803,379.32,973.92,932.92,284.21,822.51,833.81,807.11,991.91,832.41,732.11,771.300000000394349
Selling & Marketing Expenses 000000000000-157.800-690000000000
SG&A 2,817.32,761.72,843.43,177.83,343.83,379.32,973.92,932.92,284.21,822.51,833.81,807.11,834.11,832.41,732.11,702.31,489.71,355.71,259.61,190737.5546532.8429.7394349
Other Expenses -9.3560.6582.3648.5666.7-15.6-18.3-71.3-36.9-39.664.50000169.5000000000
Operating Expenses 3,2763,728.33,861.54,198.34,459.84,513.83,945.23,864.42,901.62,010.82,0382,032.72,230.52,052.41,937.51,965.31,868.81,5441,435.11,356.7843.3626.7604.4481.7439385
Operating Income 1,3871,064.1860.3723.31,137.533.8823.2827.9326.41,034.71,035.61,047.41,024.1916.71,018.81,0901,127.61,165.21,055763.2450.7400.9248.3268231211
Operating Income Ratio 0.1880.1530.1260.1030.1430.0040.1050.1080.0540.2210.2240.2340.230.2170.2490.2640.2890.3330.3210.2560.2370.2920.2110.2580.2460.245
Total Other Income Expenses Net -319.7-660.6-361.3-997.7-231.7-1,129-941.1-688-950.1-417.6-263.7-266.4-75.2-238.7-148.3-68.5-194.7-6.1-56.6-81.1-90.8-12-7.4000
Income Before Tax 1,067.3403.5499-274.4905.8-271.1479.6401.612.3943.9981.1990.1978.9860.2998.21,121.81,131.61,1691,040.7731.5437.5388.9240.9268231211
Income Before Tax Ratio 0.1440.0580.073-0.0390.113-0.0340.0610.0520.0020.2020.2120.2210.220.2040.2440.2720.290.3340.3170.2450.230.2830.2040.2580.2460.245
Income Tax Expense 42.2112.353.5-137-225.7108.2-1,359.6100-36.6224.9221.9237.2218.9263.3280.8272.3357.9334307.3189.6146.8131.191.1928166
Net Income 1,024231.4401.6-137.41,131.6-379.21,839.6302.949.7720.1761755760.8596.9717.4848.6773.2834.5732.5541.8346.3257.8149.8176150145
Net Income Ratio 0.1380.0330.059-0.020.142-0.0480.2350.0390.0080.1540.1650.1690.1710.1410.1750.2060.1980.2390.2230.1820.1820.1880.1270.1690.160.168
EPS 4.911.391.93-0.665.52-1.869.111.510.274.264.494.324.062.983.343.733.283.432.962.221.671.330.770.910.770.75
EPS Diluted 4.881.381.91-0.665.47-1.869.031.50.264.194.434.294.032.973.323.723.263.42.932.191.641.310.770.910.770.75
EBITDA 2,338.71,990.51,955.31,7562,271.12,175.42,792.62,415.51,935.61,3851,673.41,692.51,459.21,734.31,652.81,502.11,577.51,374.81,353.91,106.7735.6426.2271.7291.1253237
EBITDA Ratio 0.3160.2870.2860.250.2850.2740.3570.3140.3230.2960.3620.3780.3280.4110.4040.3640.4050.3930.4120.3710.3870.3110.2310.280.2690.275